🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

DXN Limited

5 posts
Read More

DXN (ASX: DXN) backlog hits A$40.9m as AI data-centre contracts reshape FY27 outlook

DXN Limited has entered FY27 with A$40.9 million of contracted backlog, almost four times FY26 revenue, after two artificial-intelligence high-performance-computing data-centre wins transformed its forward workload. The opportunity is potentially much larger, but FY26 still produced falling revenue and a wider loss, making successful execution of the first AI module the critical proof point.